Artia Global Partners LP
MIAMI, FL · CIK 1937964 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2022 · limited partnership
- Assets managed$778.9m
- Staff5 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $778.9m gross assets
- Form ADV · 2026-03-31SEC adviser record
- Legal entityARTIA GLOBAL PARTNERS LP (US)
- Kindhedge funds
- Others nearbyMiami, FL
As an employer
- Offices in1 country
- Private fundshedge 1
$526.0m
reported value
+18.6% vs Q1 2026
47positions
66.5%in top 10
7 new
11 added
3 reduced
8 sold out
vs Q1 2026
Options: 0 call positions (— notional), 1 put positions ($15.8m notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ABIVAX SA ABVX | $68.8m13.08% | Reduced -84.3k |
| INSMED INC INSM | $62.8m11.94% | Reduced -39.7k |
| TREVI THERAPEUTICS INC TRVI | $41.2m7.84% | Added +197.2k |
| BRIGHTSPRING HEALTH SVCS INC BTSG | $36.1m6.86% | Added +463.5k |
| REVOLUTION MEDICINES INC RVMD | $34.7m6.60% | Added +60.4k |
| ARGENX SE ARGX | $27.6m5.25% | Unchanged |
| ALKERMES PLC ALKS | $23.5m4.47% | New |
| TRAVERE THERAPEUTICS INC TVTX | $19.3m3.66% | Added +268.3k |
| ASTRAZENECA PLC AZN | $18.7m3.55% | Added +3.0k |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $17.1m3.25% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $15.9m3.02% | Unchanged |
| QUEST DIAGNOSTICS INC DGX | $13.8m2.62% | Added +24.3k |
| IONIS PHARMACEUTICALS INC IONS | $11.4m2.18% | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT | $11.0m2.09% | Unchanged |
| ALUMIS INC ALMS | $7.8m1.49% | Reduced -46.5k |
| VIKING THERAPEUTICS INC VKTX | $7.1m1.34% | Unchanged |
| CELCUITY INC CELC | $6.2m1.18% | Added +43.7k |
| CYTOKINETICS INC CYTK | $6.0m1.14% | Added +54.4k |
| MERCK & CO INC MRK | $6.0m1.14% | Unchanged |
| RAPPORT THERAPEUTICS INC RAPP | $5.8m1.10% | Unchanged |
| JOHNSON & JOHNSON JNJ | $5.7m1.09% | Unchanged |
| GUARDANT HEALTH INC GH | $5.7m1.09% | New |
| ABSCI CORPORATION ABSI | $5.4m1.02% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $5.3m1.01% | Unchanged |
| SIONNA THERAPEUTICS INC SION | $5.3m1.00% | Unchanged |
| ASCENDIS PHARMA A/S ASND | $4.7m0.90% | New |
| ROIVANT SCIENCES LTD ROIV | $4.6m0.87% | Unchanged |
| PALISADE BIO INC PALI | $4.2m0.79% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $4.0m0.76% | Added +33.3k |
| BIOGEN INC BIIB | $4.0m0.76% | Unchanged |
| XENON PHARMACEUTICALS INC XENE | $3.9m0.75% | Unchanged |
| BELITE BIO INC BLTE | $3.8m0.73% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $3.7m0.71% | Unchanged |
| PROKIDNEY CORP PROK | $3.7m0.70% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $3.7m0.70% | Added +51.2k |
| ORUKA THERAPEUTICS INC ORKA | $3.2m0.60% | New |
| PROTAGONIST THERAPEUTICS INC PTGX | $2.8m0.53% | Added +20 |
| UNITED THERAPEUTICS CORP DEL UTHR | $2.7m0.52% | Unchanged |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $2.7m0.51% | Unchanged |
| KINIKSA PHARMACEUTICALS INTL KNSA | $1.9m0.35% | Unchanged |
| COMPASS THERAPEUTICS INC CMPX | $839.2k0.16% | New |
| PRAXIS PRECISION MEDICINES I PRAX | $837.0k0.16% | Unchanged |
| KODIAK SCIENCES INC KOD | $663.1k0.13% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $612.3k0.12% | Unchanged |
| NUVALENT INC COM | $605.1k0.12% | Unchanged |
| PEPGEN INC PEPG | $369.6k0.07% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $355.1k0.07% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| ELI LILLY & CO LLY | $35.2m38.2k shares |
| TERNS PHARMACEUTICALS INC | $5.5m104.8k shares |
| ASCENDIS PHARMA A/S | $4.1m17.7k shares |
| ABBVIE INC ABBV | $3.2m14.5k shares |
| SOLENO THERAPEUTICS INC SLNO | $2.3m68.5k shares |
| BRIDGEBIO PHARMA INC BBIO | $1.5m20.4k shares |
| APOGEE THERAPEUTICS INC | $495.4k5.9k shares |
| AVALO THERAPEUTICS INC AVTX | $432.5k29.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $15.8m100.0k shares | New |